| scholarly article | Q13442814 |
| P50 | author | Lidan Wang | Q90700095 |
| Qiong Xu | Q90700098 | ||
| P2093 | author name string | Yang Wang | |
| Kai Zheng | |||
| Xinlin Li | |||
| P2860 | cites work | Double-blind randomized pilot trial evaluating the efficacy of oral propranolol on infantile haemangiomas in infants < 4 months of age | Q56996636 |
| Quinidine reduces clearance of (+)-propranolol more than (-)-propranolol through marked reduction in 4-hydroxylation | Q68825081 | ||
| Propranolol disposition in Chinese subjects of different CYP2D6 genotypes | Q71731573 | ||
| Low-dose propranolol regimen for infantile haemangioma | Q85248138 | ||
| Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas? | Q88782330 | ||
| Infantile hemangioma: Efficacy of low-dose propranolol and of intralesional bleomycin injection for propranolol non-response | Q92301601 | ||
| Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid | Q93022711 | ||
| Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action | Q33574011 | ||
| The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies | Q34209504 | ||
| Early growth of infantile hemangiomas: what parents' photographs tell us. | Q34349260 | ||
| Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment | Q34563146 | ||
| A randomized, controlled trial of oral propranolol in infantile hemangioma. | Q34668015 | ||
| Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. | Q35020514 | ||
| Diagnosis and Management of Infantile Hemangioma | Q35791215 | ||
| Infantile haemangiomas that failed treatment with propranolol: clinical and histopathological features | Q38218244 | ||
| The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action | Q38246692 | ||
| Infantile haemangioma | Q39089425 | ||
| Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey. | Q40424734 | ||
| Effect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteers | Q41593701 | ||
| Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus | Q41916954 | ||
| Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation. | Q42694246 | ||
| Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy | Q43449364 | ||
| Propranolol-resistant infantile haemangiomas. | Q44668179 | ||
| Can the extent of heart rate reduction predict the clinical response of infantile haemangiomas to propranolol? | Q48101717 | ||
| Infantile haemangioma: part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. | Q51867476 | ||
| Role of intralesional bleomycin and intralesional triamcinolone therapy in residual haemangioma following propranolol. | Q52582318 | ||
| Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol. | Q52583419 | ||
| Interventions for infantile haemangiomas of the skin. | Q53280418 | ||
| Evaluation of the efficacy and safety of propranolol, timolol maleate, and the combination of the two, in the treatment of superficial infantile haemangiomas | Q56976475 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | infantile hemangioma | Q52771370 |
| P304 | page(s) | 8732871 | |
| P577 | publication date | 2020-03-07 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Influence of Cytochrome P450 2D6 Polymorphisms on the Efficacy of Oral Propranolol in Treating Infantile Hemangioma | |
| P478 | volume | 2020 |
Search more.